No evidence of a correlation between BCL10 expression and API2-MALT1 gene rearrangement in ocular adnexal MALT lymphoma

Pathology International

Volumn 54, Issue 1, 2004, Pages 16-25

  Adachi, Akiko ^a   Tamaru, Jun Ichi ^a   Kaneko, Kou ^b   Kuroda, Hajime ^a   Miura, Ichiro ^a   Kojima, Takayoshi ^b   Hoshino, Shigeru ^b   Ichinohasama, Ryo ^c   Itoyama, Shinji ^a  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

^b SAITAMA RED CROSS HOSPITAL   (Japan)

^c TOHOKU UNIVERSITY   (Japan)

Author keywords

API2 MALT1; BCL10; Malt lymphoma; Ocular adnexa

Indexed keywords

INHIBITOR OF APOPTOSIS PROTEIN; INHIBITOR OF APOPTOSIS PROTEIN 2; PROTEIN BCL 10; UNCLASSIFIED DRUG;

ADULT; AGED; B LYMPHOCYTE; CELL NUCLEUS; CLINICAL FEATURE; CONTROLLED STUDY; CYTOPLASM; DISEASE COURSE; FEMALE; FUSION GENE; GENE REARRANGEMENT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LARGE CELL LYMPHOMA; LYMPHOID HYPERPLASIA; LYMPHOPROLIFERATIVE DISEASE; MAJOR CLINICAL STUDY; MALE; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; NATURAL KILLER CELL; OCULAR ADNEXAL LYMPHOPROLIFERATIVE DISORDER; OCULAR ADNEXAL MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECURRENT DISEASE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; T CELL LYMPHOMA;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADULT; AGED; AGED, 80 AND OVER; CELL NUCLEUS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE REARRANGEMENT; HUMANS; LYMPHOMA, B-CELL, MARGINAL ZONE; MALE; MIDDLE AGED; NEOPLASM STAGING; ONCOGENE PROTEINS, FUSION; ORBITAL NEOPLASMS; RETROSPECTIVE STUDIES; RNA, MESSENGER; RNA, NEOPLASM; TUMOR MARKERS, BIOLOGICAL;

EID: 3242766846     PISSN: 13205463     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1827.2004.01580.x     Document Type: Review

References (46)

1. Coupland SE, Krause L, Dlecluse H-J et al. Lymphoproliferative lesions of the ocular adnexa: analysis of 112 cases. Ophthalmology 1998; 105: 1430-41.
2. Johnson TE, Tse DT, Byrne GE Jr et al. Ocular-adnexal lymphoid tumors: a clinicopathologic and molecular genetic study of 77 patients. Ophthalmic Plast Reconstr Surg 1999; 15: 171-9.
3. White WL, Ferry JA, Harris NL, Grove AS Jr. A clinicopathologic study with identification of lymphomas of mucosa-associated lymphoid tissue type. Ophthalmology 1995; 102: 1994-2006.
4. Isaacson PG. Mucosa-associated lymphoid tissue lymphoma. Semin Hematol 1999; 36: 139-47.
5. Sanchez-Beato M, Sanchez-Aguilera A, Piris MA. Cell cycle deregulation in B-cell lymphomas. Blood 2003; 101: 1220-35.
6. Vega F, Medeiros LJ. Marginal-zone B-cell lymphoma of extranodal mucosa-associated lymphoid tissue type: molecular genetics provides new insights into pathogenesis. Adv Anat Pathol 2001; 8: 313-26.
7. Willis TG, Jadayel DM, Du MQ et al. Bcl10 is involved in t(1;14)(p22;q32) of MALT B cell lymphoma and mutated multiple tumor types. Cell 1999; 96: 35-45.
8. Zhang Q, Siebert R, Yan M et al. Inactivating mutation and overexpression of BCL10, a caspase recruitment domain-containing gene, in MALT lymphoma with t t(1;14)(p22;q32). Nat Genet 1999; 22: 63-8.
9. Du MQ, Peng H, Liu H et al. BCL10 gene mutation in lymphoma. Blood 2000; 95: 3885-90.
10. Ye H, Dogan A, Karran L et al. BCL10 expression in normal and neoplastic lymphoid tissue: nuclear localization in MALT lymphoma. Am J Pathol 2000; 157: 1147-54.
11. Levine EG, Arthur DC, Machnicki J et al. Four new recurring translocations in non-Hodgkin lymphoma. Blood 1989; 74: 1796-800.
12. Auer IA, Gascoyne RD, Connors JM et al. t(11;18)(q21;q21) is the most common translocation in MALT lymphomas. Ann Oncol 1997; 8: 979-85.
13. Ott G, Katzenberger T, Greiner A et al. The t(11;18)(q21;q21) chromosome translocation is a frequent and specific aberration in low-grade but not high-grade malignant non-Hodgkin's lymphomas of the mucosa-associated lymphoid tissue (MALT-) type. Cancer Res 1997; 57: 3944-8.
14. Dierlamm J, Baens M, Wlodarska I et al. The apoptosis inhibitor gene API2 and a novel 18q gene, MLT, are recurrently rearranged in the t(11;18)(q21;q21) associated with mucosa-associated lymphoid tissue lymphomas. Blood 1999; 93: 3601-9.
15. Rosenwald A, Ott G, Stilgenbauer S et al. Exclusive detection of the t(11;18)(q21;q21) in extranodal marginal zone B cell lymphomas (MZBL) of MALT type in contrast to other MZBL and extranodal large B cell lymphomas. Am J Pathol 1999; 155: 1817-21.
16. Dierlamm J, Baens M, Stefanova-Ouzounova M et al. Detection of t(11;18)(q21;q21) by interphase fluorescence in situ hybridization using API2 and MLT specific probes. Blood 2000; 96: 2215-18.
17. Remstein ED, James CD, Kurtin PJ. Incidence and subtype specificity of API2-MALT1 fusion translocations in extranodal, nodal, and splenic marginal zone lymphomas. Am J Pathol 2000; 156: 1183-8.
18. Baens M, Maes B, Steyls A, Geboes K, Marynen P, Wolf-Peelers CD. The product of the t(11;18), an API2-MLT fusion, marks nearly half of gastric MALT type lymphomas without large cell proliferation. Am J Pathol 2000; 156: 1433-9.
19. Inagaki H, Okabe M, Seto M, Nakamura S, Ueda R, Eimoto T. API2-MALT1 fusion transcripts involved in mucosa-associated lymphoid tissue lymphoma. Am J Pathol 2001; 158: 699-706.
20. Yonezumi M, Suzuki R, Suzuki H et al. Detection of API2-MALT1 chimaeric gene in extranodal and nodal marginal zone B-cell lymphoma by reverse transcription polymerase chain reaction (PCR) and genomic long and accurate PCR analyses. Br J Haematol 2001; 115: 588-94.
21. Liu H, Ye H, Dogan A et al. t(1118 (q21;q21) is associated with advanced mucosa-associated lymphoid tissue lymphoma that expresses nuclear BCL10. Blood 2001; 98: 1182-7.
22. Uren GA, O'Rourke K, Aravind LA et al. Identification of paracaspases and metacaspases: two ancient families of caspase-like proteins, one of which plays a key role in MALT Lymphoma. Mol Cell 2000; 6: 961-7.
23. Lucas PC, Yonezumi M, Inohara N et al. Bcl10 and MALT1, independent targets of chromosomal translocation in malt lymphoma, cooperate in a novel NF-kappa B signaling pathway. J Biol Chem 2001; 276: 19012-19.
24. Stoffel A, Le Beau MM. The API2/MALT1 fusion product may lead to germinal center B cell lymphomas by suppression of apoptosis. Hum Hered 2001; 51: 1-7.
25. Maes B, Demunter A, Peeters B, Wolf-Peeters CD. BCL10 mutation does not represent an important pathogenic mechanism in gastric MALT-type lymphoma, and the presence of the API2-MLT fusion is associated with aberrant nuclear BCL10 expression. Blood 2002; 99: 1398-404.
26. Jaffe ES, Harris NL, Stein H, Vardiman JW. World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon: IARC Press, 2001.
27. Carbone PP, Kaplan HS, Musshoff K, Smithers DW, Tubiana M. Report of the committee on Hodgkin's disease staging classification. Cancer Res 1971; 31: 1860-1.
28. Knowles DM, Jakobiec FA, Mcnally L, Burke JC. Lymphoid hyperplasia and malignant lymphoma occurring in the ocular adnexa (orbit, conjunctiva, and eyelids): a prospective multi-parametric analysis of 108 cases during 1977-87. Hum Pathol 1990; 21: 959-73.
29. Mannami T, Yoshino T, Oshima K et al. Clinical, histopathological, and immunogenetic analysis of ocular adnexal lymphoproliferative disorders: Characterization of MALT lymphoma and reactive lymphoid hyperplasia. Mod Pathol 2001; 14: 641-9.
30. Chan JKC, Ng CS, Isaacson PG. Relationship between high-grade lymphoma and low grade B-cell mucasa-associated lymphoid tissue lymphoma (MALToma) of the stomach. Am J Pathol 1990; 136: 1153-64.
31. Ranaldi R, Goteri G, Baccarini MG, Mannello B, Beardi I. A clinicopathological study of 152 surgically treated primary gastric lymphomas with survival analysis of 109 high grade tumours. J Clin Pathol 2002; 55: 346-51.
32. Montalban C, Manzanal A, Castrillo JM, Escribano L, Bellas C. Low grade gastric B-cell MALT lymphoma progressing into high grade lymphoma: Clonal identity of the two stages of the tumour, unusual bone involvement and leukaemic dissemination. Histopathology 1995; 27: 89-91.
33. Peng HZ, Du MQ, Diss TC, Isaacson PG, Pan L. Genetic evidence for a clonal link between low- and high-grade components in gastric MALT B-cell lymphoma. Histopathology 1997; 30: 425-9.
34. Hatano B, Ohshima K, Tsuchiya T, Yamaguchi T, Kawasaki C. Clinicopathological features of gastric B-cell lymphoma: A series of 317 cases. Pathol Int 2002; 52: 677-82.
35. Yoshino T, Omonishi K, Kobayashi K et al. Clinicopathological features of gastric mucosa assoiciated lymphoid tissue (MALT) lymphomas: high grade transformation and comparison with diffuse large B cell lymphomas without MALT lymphoma features. J Clin Pathol 2000; 53: 187-90.
36. Hoeve MA, Gisbertz IAM, Schouten HC et al. Gastric low-grade MALT lymphoma, high-grade MALT lymphoma and diffuse large B cell lymphoma show different frequencies of trisomy. Leukemia 1999; 13: 799-807.
37. Nakamura S, Yao T, Aoyagi K, lida M, Fujishima M, Tsuneyoshi M. Helicobacter pylori and primary gastric lymphoma. Cancer 1997; 79: 3-11.
38. Du MQ, Peng HZ, Singh N, Isaacson PG, Pan LX. The accumulation of p53 abnormality is associated with progression of mucosa-associated lymphoid tissue lymphoma. Blood 1995; 86: 4587-93.
39. Peng HZ, Diss TC, Issacson PG, Pan LX. C-myc gene abnormalities in mucosa associated lymphoid tissue (MALT) lymphomas. J Pathol 1997; 181: 381-6.
40. Okabe M, Inagaki H, Ohshima K et al. API2-MALT1 fusion defines a distinctive clinicopathologic subtype in pulmonary extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue. Am J Pathol 2003; 162: 1113-22.
41. Liu H, Ye H, Ruskone-Fourmestraux A et al. t(11;18) is a marker for all stage gastric MALT lymphomas that will not respond to H. pylori eradication. Gastroenterology 2002; 122: 1286-94.
42. Kobayashi Y, Nakata M, Maekawa M et al. Detection of t(11;18) in MALT-type lymphoma with dual-color fluorescence in situ hybridization and reverse transcriptase-polymerase chain reaction analysis. Diag Mol Pathol 2001; 10: 207-13.
43. Motegi M, Yonezumi M, Suzuki H et al. API2-MALT1 API2-MALT1 chimeric transcripts involved in mucosa-associated lymphoid tissue type lymphoma predict heterogeneous products. Am J Pathol 2000; 156: 807-12.
44. Kalla J, Stilgenbauer S, Schaffner C et al. Heterogeneity of the API2-MALT1 gene rearrangement in MALT-type lymphoma. Leukemia 2000; 14: 1967-74.
45. Streubel B, Lamprecht A, Dierlamm J et al. t(14;18)(q32;q21) involving IGH and MALT1 is a frequent chromosomal aberration in MALT lymphoma. Blood 2003; 101: 2335-9.
46. Li C, Inagaki H, Kuo T, Hu S, Okabe M, Eimoto T. Primary cutaneous marginal zone B-cell lymphoma. Am J Surg Pathol 2003; 27: 1061-69.